Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R K Zeldin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Experimental Psychology. Animal Behavior Processes|October 1, 1986
Rats acquire spatial learning setsR K Zeldin, D S Olton
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 23, 2013
Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitisA Didier, H-J Malling, M Worm, et al.
Clinical Therapeutics|September 18, 2001
Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trialW J Elliott, D A Calhoun, P T DeLucca, et al.
Clinical Pediatrics|July 1, 2009
Adding omalizumab to the therapy of adolescents with persistent uncontrolled moderate--severe allergic asthmaM Massanari, H Milgrom, S Pollard, et al.
Journal of Thrombosis and Haemostasis : JTH|April 27, 2017
Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpuraF Peyvandi, M Scully, J A Kremer Hovinga, et al.
Pulmonary Pharmacology & Therapeutics|April 27, 2010
Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patientsC Vogelmeier, C Verkindre, D Cheung, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 23, 2013
Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapyV Baron-Bodo, S Horiot, A Lautrette, et al.
Allergy|January 30, 2015
Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cellsL Mascarell, S Rak, M Worm, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Experimental Psychology. Animal Behavior Processes|October 1, 1986
Rats acquire spatial learning setsR K Zeldin, D S Olton
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 23, 2013
Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitisA Didier, H-J Malling, M Worm, et al.
Clinical Therapeutics|September 18, 2001
Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trialW J Elliott, D A Calhoun, P T DeLucca, et al.
Clinical Pediatrics|July 1, 2009
Adding omalizumab to the therapy of adolescents with persistent uncontrolled moderate--severe allergic asthmaM Massanari, H Milgrom, S Pollard, et al.
Journal of Thrombosis and Haemostasis : JTH|April 27, 2017
Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpuraF Peyvandi, M Scully, J A Kremer Hovinga, et al.
Pulmonary Pharmacology & Therapeutics|April 27, 2010
Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patientsC Vogelmeier, C Verkindre, D Cheung, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 23, 2013
Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapyV Baron-Bodo, S Horiot, A Lautrette, et al.
Allergy|January 30, 2015
Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cellsL Mascarell, S Rak, M Worm, et al.
Pageof 1